Pioglitazone + Metformin

Composition

Pioglitazone + Metformin is a combination of two anti-diabetic agents: Pioglitazone (thiazolidinedione) and Metformin (biguanide). This formulation helps manage blood sugar levels effectively in patients with type 2 diabetes.

Indications

Used for the treatment of type 2 diabetes mellitus (non-insulin-dependent diabetes), particularly when metformin alone is insufficient for glycemic control.

Side effects

Common side effects may include diarrhea, loss of appetite, nausea, vomiting, headache, and localized swelling (edema). Most side effects are mild and may resolve over time, but persistent or worsening symptoms should be discussed with a healthcare provider.

Precautions

Precautions include monitoring for signs of low blood sugar and consulting with a doctor if you have a history of heart disease, liver, or kidney issues. It is crucial not to stop taking this medication without medical advice, as discontinuation may lead to increased blood sugar levels.

Contraindications

Contraindicated in patients with type 1 diabetes, severe renal or hepatic impairment, or those with a known hypersensitivity to any component of this medication.

Dosage and administration

Take as directed by a physician, ideally with food to minimize gastrointestinal discomfort.

Countries

Available across various LATAM countries, including Brazil, Mexico, Argentina, Colombia, and Chile.

Available Forms

Typically available in tablet form for oral administration.

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai